Neoprobe Corporation - Medical Equipment - Deals and Alliances Profile -Aarkstore Enterprise

Neoprobe Corporation - Medical Equipment - DealsNov 02, 2009: Neoprobe Reports Net Sales Of $2.6
and Alliances Profile is an essential source forMillion In Q3 2009
company data and information. The profile examinesSep 08, 2009: Laureate Pharma Signs Manufacturing
the company's key business structure and operations,Agreement With Neoprobe
history and products, and provides summary analysisScope
of its key revenue lines and strategy as well as- Provides key company information for business
highlighting the company's major recent financial deals.intelligence needs
Neoprobe Corporation (Neoprobe) is a biomedical- Gives information on the company's major recent
company principally engaged in the development andfinancial deals including mergers & acquisitions,
commercialization of products that enhance criticalasset transactions, PE/VC deals, equity offerings,
intraoperative, diagnostic and therapeutic treatmentdebt offerings and partnerships.
needs of patients and physicians. The product- Data is supplemented with details on the company's
portfolio of Neoprobe includes gamma detectionhistory, key executives, business description,
systems, detector probes, accessories, and bloodlocations and subsidiaries as well as a list of products
flow measurement products including Quantix/OR andand services and the latest available company
Quantix/ND. Pipeline products of the company includestatement.
Lymphoseek, RIGS and Activated Cellular Therapy.Reasons to buy
The company is headquartered at Dublin, Ohio, the- A quick "one-stop-shop" to understand the
US. In March 2009, the company introduced a newcompany.
high energy gamma detection probe at the Society- Support sales activities by understanding your
of Surgical Oncology's 62nd Annual Cancercustomers' businesses.
Symposium.- Qualify prospective partners and suppliers.
And More inside the report…- Understand and respond to your competitors'
Recent Developmentsbusiness structure, strategy and prospects through.
Dec 11, 2009: Neoprobe Unveils Phase 3 Data- Understanding the key deals which have shaped the
Evaluating Lymphoseekcompany.